News | October 08, 2014

Cardinal Health Hosts Physician Panel on Balance of Clinical Excellence and Cost Effectiveness in Interventional Cardiology at TCT

October 8, 2014 — At the recent Transcatheter Cardiovascular Therapeutics (TCT) meeting, representatives from Cardinal Health and physicians from leading healthcare institutions led discussions to help interventionalists explore the balance between innovative approaches to lowering healthcare costs and maintaining high-quality patient care.

On Tuesday, Sept. 16, Cardinal Health Medical Segment CEO Don Casey discussed healthcare industry business model innovation before joining co-chair Martin B. Leon, M.D., from New York-Presbyterian Hospital/Columbia University Medical Center and panelists Michael Jaff, DO, from Massachusetts General Hospital; David Cohen, M.D., from Saint Luke’s Mid America Heart Institute; and Mark Burket, M.D., University of Toledo Medical Center for a panel entitled, “The Balance of Clinical Excellence and Cost-Effectiveness in Interventional Cardiology: Today and Tomorrow.”

“The healthcare system today, more than ever, needs new, innovative solutions that will allow providers to deliver great patient care while being fiscally prudent,” said Casey. “We believe there is an opportunity to build new solutions that combine product, services and analytics to bring more value to our customers.”

On the TCT show floor, Cardinal Health presented its interventional solution sets that help optimize interventional healthcare, including:

  • Operational efficiency — ensuring the right product in the right place at the right time from point of order to point of care;
  • Product quality — offering high-quality, cost-effective products from basic essentials to complex procedures to promote excellent patient care; and
  • Smart analytics — transforming data into actionable clinical, operational and financial insights.


For more information: www.cardinalhealth.com/interventional


Related Content

Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Elixir Medical, a developer of technologies to treat cardiovascular disease, has announced new clinical ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...

Home October 23, 2025
Home
News | Cath Lab

Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...

Home October 16, 2025
Home
News | Cath Lab

Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...

Home October 07, 2025
Home
News | Cath Lab

Sept. 22, 2025 — Nicklaus Children's Heart Institute in Miami, Florida, is now offering bedside transcatheter patent ...

Home September 23, 2025
Home
Subscribe Now